Menopause May Partially Explain Age-Related Increased Risk of MASLD Fibrosis: A Causal Mediation Analysis
- 27 September 2025
- journal article
- Published by Elsevier in Clinical Gastroenterology and Hepatology
- Vol. 24 (6) , 1729-1731
Abstract
No abstract availableKeywords
Funding Information
- National Institutes of Health (DK056338)
- Baylor College of Medicine
- National Institute on Minority Health and Health Disparities (K23MD016955)
This publication has 9 references indexed in Scilit:
- Menopause and metabolic dysfunction-associated steatotic liver diseaseMaturitas, 2024
- PNPLA3 rs738409, age, diabetes, sex, and advanced fibrosis jointly contribute to the risk of major adverse liver outcomes in metabolic dysfunction-associated steatotic liver diseaseHepatology, 2024
- Forecasted 2040 global prevalence of nonalcoholic fatty liver disease using hierarchical bayesian approachClinical and Molecular Hepatology, 2022
- Establishment of a new nonalcoholic steatohepatitis model; Ovariectomy exacerbates nonalcoholic steatohepatitis-like pathology in diabetic ratsJournal of Pharmacological and Toxicological Methods, 2022
- Mortality Related to Nonalcoholic Fatty Liver Disease Is Increasing in the United StatesHepatology Communications, 2019
- NASH Leading Cause of Liver Transplant in Women: Updated Analysis of Indications For Liver Transplant and Ethnic and Gender VariancesAmerican Journal of Gastroenterology, 2018
- Gender and menopause impact severity of fibrosis among patients with nonalcoholic steatohepatitisHepatology, 2013
- Clinical and histological determinants of nonalcoholic steatohepatitis and advanced fibrosis in elderly patientsHepatology, 2013
- Fatty Acid Oxidation is Decreased in the Liver of Ovariectomized RatsHormone and Metabolic Research, 2009